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Background on AB use in URTI
 Inappropriate use of AB propagates antimicrobial resistance
 Most URTI are viral and self-limiting conditions, but often 
inappropriately treated with antibiotics
 AB use high in children due to concerns about susceptibility to 
bacterial infections and secondary complications
 Inappropriate use includes AB self-medication by public:
• AB purchased in pharmacies without prescription (OTC) 
• left-over AB from previous courses
 Reasons for AB self-medication in developed countries context:
• poor regulation enforcement of AB as prescription-only-
medicines (POM)
• patients’ misconceptions on AB efficacy in URTI
Some facts about Macedonia
 2 million inhabitants
 South East Europe, EU candidate country
WB: Upper middle income country
 Health expenditure: 7% of GDP
Medicines: 14% of health expenditure
 2/3 Government health expenditure
 Universal health insurance
 Patients entitled to GPs & children to paediatricians
 National list of reimbursable medicines, incl. AB

AB national strategy in 2014
Introduction of  health education campaigns to raise awareness 
on adequate AB use and danger of AMR
• Nation-wide mass media (TV) campaign on AB use 
• Kindergarten seminars for parents on AB use
• Seminars for health workers on RTI management and AB 
prescribing
Study objectives
• Assess parental knowledge, attitudes and practice re: AB & URTI
• Evaluate impact of AB inteventions on parental awareness and 
action re: AB for URTI (2015 vs 2014)
05/2014 - 05/2015 
TV campaign automn 2014
Kindergarten sessions automn 2014
H. workers seminars automn 2014
Criminal provision on OTC sales of 
antibiotics added to the Law May 2015
Study methodology
• 2 community-based surveys in May 2014 & 2015 (pre & post 
intervention)
• Parents of children < 15 years in 3/8 regions (25%) in MK
• Recruitment near markets, pharmacies, paediatric offices, 
schools
• Structured questionnaire (EC Eurobarometer 407 AMR, 2013)
• Descriptive quantitative statistical analysis (frequencies, %), 
SPSS
• Student t-test / Mann-Whitney U test for associations (p<0.05)
Method:
Face-to-face interview with anonymous 33-item KAP questionnaire
Content:
1. Socioeconomic/demographic characteristics - parents & children
2. Parental knowledge and attitudes about AB and ARI 
▫ Usefulness of AB to treat ARI & risks of unnecessary use
3. Info on ARI management and use of AB by children & parents
▫ AB use in the preceding year
▫ Sources of  AB
▫ Reasons for taking AB without prescriptions
Questionnaire description
Parents’ demography 2014 (n=403) 2015 (n=400) p
Mean age (years) 33±6.4 32.3±6.2 0.1575
Female gender 76.4% 78% 0.5009
Minorities 12.7% 11.2% 0.3835
Urban residents 72% 68.3% 0.2165
Married 94.5% 95.3% 0.9987
University degree 35.5% 36.8% 0.7015
Employed 68.7% 71.3% 0.5365
Children’ demography 2014 (n=403) 2015 (n=400) p
Mean age (years) 6.9±4.2 5.6±3.8 0.1564
Younger than 5 years 48.4% 52.5% 0.2456
Female gender 44.9% 51.5% 0.0475*
With siblings (<18y) 44.9 49.8% 0.1564
49% of Europeans don’t know AB are ineffective against viruses (Eurobarometer
2013). In Bulgaria, Cyprus, Romania and Portugal these figures were over 80%.
Figure 1: Parental knowledge on antibiotics in 2014 and 2015
40% of Europeans don’t know AB are ineffective against colds and flu.
Fig 2: Parental expectations on URTI symptoms that improve faster with AB (%)
Figure 3: Parental attitudes towards AB prescribing and use (%)
Only a third of EU respondents remember receiving information about not 
taking AB unnecessarily in the last 12 months (France 65%, Portugal 12%). 
Figure 4: Source of information about not taking antibiotics unnecessary (%)
Reasons for taking AB in the last year in adults (R) and children (L)
80% of children used AB in the last 
year.
50% of adults respondents used AB in 
the last year vs. average 35% in EU, 
2013. (Malta, Cyprus, Romania 47%)
Table 2: Patterns of AB provision for parents and children in preceding year (%)
Source of AB (PARENTS) 2014 (n=203) 2015 (n=213) p
Doctor’s prescription 78.8% (160/203) 78.4% (167/213) 0.9208
OTC sale in pharmacies 8.87% (18/203) 9.9% (21/213) 0.7284
Left-over AB at home 10.84% (22/203) 11.7% (25/213) 0.7496
Don’t remember / DK 1.5% (3/203) 0% (0/213) 0.1442
Source of AB (CHILDREN) 2014 (n=318) 2015 (n=334) p
Doctor’s prescription 88.7%  (282/318) 94.9% (317/334) 0.0047*
OTC sale in pharmacies 5.7% (18/318) 1.2% (4/334) 0.0016*
Left-over AB at home 4.4% (14/318) 3.9% (13/334) 0.9489
Don’t remember / DK 1.2% (4/318) 0% (0/334) 0.0674

Reported use of non-prescribed AB
• Reasons for use in children
- same AB prescribed by their paediatrician in the past for similar 
condition
• Reasons for use in parents
- same AB prescribed by their MD in the past for similar condition
- no time for doctors
- condition not serious
Further analysis on factors associated with AB
misuse & parental poor knowledge (logistic regression)  
Major findings
• Low level of public knowledge on AB/URTI (average EU)
• High expectations for URTI quick recovery with AB treatment
• Incomplete AB courses 
→ low adherence & AMR 
→ left-over AB for self – medication & AMR
• Parents better informed about AB use/AMR in 2015, mainly by 
MDs & mass media
• High rate (20%) of AB self-medication in 2014 and 2015 for 
URTI in parents (SEE)
• Increasingly, most children (95%) treated with AB by 
paediatricians, not self-medicated by parents (=10% in Greece 
& Cyprus)
Discussion
• Monitoring system for prescribed (reimbursed) AB in place, but 
tracking OTC AB sales remains a challenge during study period
• Regulation enforcement to restrict AB sales in pharmacies is vital 
• amendment to the Medicines Law for criminal provision/fines 
on OTC sales of POM in May 2015 
• Community pharmacists crucial to
• advise patients on minor ailments (no need to treat URTI with AB)
• refer to GPs, 
• advise to take full AB course
Education and more innovative pharmacy service remuniration
• Paediatric offices accessible for families 
Study limitations
- Self-reported data  re: 1 year (recall bias, over/under-reporting), 
by interviews (socially acceptable answers)
*from validated international studies, interviews for lower 
socioeconomic strata 
→ combine different methods to validate self-reports (focus groups, 
prospective observational studies), but more resources
- Restricted geographic coverage 
→ studies on national context – better, but need more resources
- Use of positive statements may enforce tendency to agree with 
questions more than disagree
* positive statements from validated international studies
→ use of double/contrary statements  to double check - but longer q
Conclusion
• Despite limitations, our study provides important data on parental 
knowledge and behaviour on AB/URTI 
• Mixed effects from AMR strategy 1 year after implementation
▫ Parental knowledge on AB use has improved
▫ Parents still self-medicated with AB
▫ But, less children treated with non-prescribed AB
• More detailed subgroup analyses and further measurements in time  
may be needed
• Results to inform future efforts to address key gaps in public
knowledge and monitor OTC practices in pharmacies
Thank you for your attention!
Any suggestions/questions?
